ATE3769T1 - 1-imidazol-2-yliden-3-thienyl-harnstoffderivate verfahren zu deren herstellung und pharmazeutische zusammensetzungen. - Google Patents

1-imidazol-2-yliden-3-thienyl-harnstoffderivate verfahren zu deren herstellung und pharmazeutische zusammensetzungen.

Info

Publication number
ATE3769T1
ATE3769T1 AT79302921T AT79302921T ATE3769T1 AT E3769 T1 ATE3769 T1 AT E3769T1 AT 79302921 T AT79302921 T AT 79302921T AT 79302921 T AT79302921 T AT 79302921T AT E3769 T1 ATE3769 T1 AT E3769T1
Authority
AT
Austria
Prior art keywords
processes
pharmaceutical compositions
ylidene
imidazole
preparation
Prior art date
Application number
AT79302921T
Other languages
English (en)
Inventor
Thomas Michael Bare
Original Assignee
Ici Americas Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Americas Inc filed Critical Ici Americas Inc
Application granted granted Critical
Publication of ATE3769T1 publication Critical patent/ATE3769T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Anesthesiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT79302921T 1979-01-19 1979-12-17 1-imidazol-2-yliden-3-thienyl-harnstoffderivate verfahren zu deren herstellung und pharmazeutische zusammensetzungen. ATE3769T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/004,675 US4230713A (en) 1979-01-19 1979-01-19 Heterocyclic tetrahydro-1-alkyl-4-oxo-1H-imidazol-2-ylidene urea and phenyl esters of tetrahydro-1-alkyl-4-oxo-1H-imidazol-2-ylidene carbamic acid compounds
EP79302921A EP0013817B1 (de) 1979-01-19 1979-12-17 1-Imidazol-2-yliden-3-thienyl-harnstoffderivate, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen

Publications (1)

Publication Number Publication Date
ATE3769T1 true ATE3769T1 (de) 1983-06-15

Family

ID=21711951

Family Applications (1)

Application Number Title Priority Date Filing Date
AT79302921T ATE3769T1 (de) 1979-01-19 1979-12-17 1-imidazol-2-yliden-3-thienyl-harnstoffderivate verfahren zu deren herstellung und pharmazeutische zusammensetzungen.

Country Status (6)

Country Link
US (1) US4230713A (de)
EP (1) EP0013817B1 (de)
JP (1) JPS55100380A (de)
AT (1) ATE3769T1 (de)
CA (1) CA1122600A (de)
DE (1) DE2965701D1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4472583A (en) * 1980-02-05 1984-09-18 The Dow Chemical Company 4-Isothiocyanato-2,6-bis-(trifluoromethyl)pyridine
DE3674054D1 (de) * 1985-04-26 1990-10-18 Hoffmann La Roche 1,3-disubstituierte imidazoliumsalze.
US4657922A (en) * 1985-05-24 1987-04-14 Mcneilab, Inc. Anxiolytic 4,5-dihydro-4-oxo-1H-imidazol-2-yl urea derivatives
DE59805833D1 (de) 1997-07-22 2002-11-07 Basf Coatings Ag Beschichtungsmittel und verfahren zu dessen herstellung
US20030220646A1 (en) * 2002-05-23 2003-11-27 Thelen Sarah L. Method and apparatus for reducing femoral fractures
WO2007073283A1 (en) * 2005-12-20 2007-06-28 Astrazeneca Ab Substituted cinnoline derivatives as gabaa-receptor modulators and method for their synthesis
US7465795B2 (en) * 2005-12-20 2008-12-16 Astrazeneca Ab Compounds and uses thereof
AR067028A1 (es) * 2007-06-19 2009-09-30 Astrazeneca Ab Compuestos y usos de los mismos 849
MA53096A (fr) * 2018-07-03 2021-05-12 Ifm Due Inc Composés et compositions destinés au traitement d'états pathologiques associés à une activité de sting

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3983135A (en) * 1974-09-23 1976-09-28 Mcneil Laboratories, Incorporated 4-Oxo-2-imidazolidinylidene ureas

Also Published As

Publication number Publication date
DE2965701D1 (en) 1983-07-21
JPS55100380A (en) 1980-07-31
CA1122600A (en) 1982-04-27
EP0013817B1 (de) 1983-06-15
US4230713A (en) 1980-10-28
EP0013817A1 (de) 1980-08-06

Similar Documents

Publication Publication Date Title
SE8200815L (sv) Kemisk forening till anvendning som mellanprodukt vid framstellning av vissa triazolforeningar
ES483767A1 (es) Procedimiento para producir n-arilsulfonil-l-argininamidas
BR9908764A (pt) Composto e seus sais farmaceuticamente aceitáveis ou ésteres hidrolisáveis in vivo, uso destes, processo para prepará-los, e, composição farmacêutica
NO900306D0 (no) Fremgangsmaate for fremstilling av nye pyrazolopyridin-forbindelser.
NL930018I1 (nl) (Piperidinylalkyl) chinazolinederivaten,werkwijze voor hun bereiding en farmaceutische preparaten die ze bevatten
FI810604L (fi) Foerfarande foer framstaellning av indanderivat
ATE102193T1 (de) Thiazolidinedionederivate.
ATE224T1 (de) 1,2-dihydro-chinolin-2-on-derivate, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel.
ES462065A1 (es) Procedimiento para la preparacion de derivados de tiazolidi-na.
DE3665711D1 (de) Novel guanidinomethylbenzoic acid derivatives
ATE3769T1 (de) 1-imidazol-2-yliden-3-thienyl-harnstoffderivate verfahren zu deren herstellung und pharmazeutische zusammensetzungen.
ES431497A1 (es) Procedimiento para preparar un derivado de s-triazol (1,5- a) piridina.
HUT64318A (en) Process for production benzodpyrane derivativs and pharmaceutical preparations containing these compounds as effective substance
FI803202L (fi) Fosfonohydroxiaettiksyra foerfarande foer dess framstaellning och dess anvaendning saosom laekemedel
SE8107524L (sv) Heterocykliska foreningar
ATE7137T1 (de) Nitrosoureum-derivate, verfahren zu deren herstellung, und diese enthaltende pharmazeutische zusammensetzungen.
ES8307791A1 (es) "procedimiento para preparar derivados de nicotinoilbenzoguanamina".
ATE772T1 (de) Thiazolderivate, ihre herstellung und sie enthaltende arzneimittel.
ATE28647T1 (de) Chinazolinonderivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln.
GB1058258A (en) Alkyl derivatives of imidazo[1,2-a]pyridines
ATE63544T1 (de) 4-cyanopiperidine-derivate, herstellung und anwendung.
FR2655042B1 (fr) Nouvelles benzothiazolinones substituees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
ATE1585T1 (de) Clavulansaeurederivate, ihre herstellung und sie enthaltende pharmazeutische praeparate.
ES475769A1 (es) Un procedimiento para preparar aminoalcohiltiodibenztiepinas
FR2315932A1 (fr) Derives d'acides quinoleine-carboxyliques et medicaments qui en contiennent

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee